Vistagen Therapeutics, Inc. revenue breakdown overview

Vistagen Therapeutics, Inc. revenue for the last year amounted to 1.06 M USD, the most of which — 1.06 M USD — came from its highest performing source at the moment, Central Nervous System Therapies, the year earlier bringing -227.30 k USD. The greatest contribution to the revenue figure was made by United States — last year it brought Vistagen Therapeutics, Inc. 1.06 M USD, and the year before that — -227.30 k USD.